Biotech | April 06, 2022
Singlera Genomics announces research collaboration with Astellas Pharma
The aim is to pursue methylation-based tools to better understand biological reactions to pharmaceuticals
The aim is to pursue methylation-based tools to better understand biological reactions to pharmaceuticals
New high-throughput, no-wash assays contribute to the development, manufacture and quality control of safer, more effective biotherapeutics
Vela Analytics can create concise, evidence-based in-house reports that help customers with the information to make timely, informed decisions about possible treatment options
The Centre will be instrumental in streamlining vaccination resources and facilitate equitable access to safe and efficacious COVID-19 vaccines
CEPI will expand its partnership with icddr,b in Bangladesh, providing near to the additional US $ 1 million in funding to advance understanding of the Nipah virus
In numerous neurological and rare disorders, where clinical characteristics can be confusing, NGS-based approaches have demonstrated considerable increases in disease detection rates over other approaches
More than 2,500 submissions are currently under review in the Food and Drug Administration's (FDA) cell and gene therapy pipeline
Twist will leverage C2i’s leadership in whole-genome cancer signatures across solid cancers to generate unique synthetic reference materials for cancer detection validation in labs across the globe
Newly formed Life Science Services business unit to offer fully integrated CDMO and Contract Testing Services
The appointment is key for DefiniGEN as they expand the service portfolio to encompass compound screening
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
